Relationship Between Immunity and Metabolism in Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer. ( RIMEC )

NCT04808817 · clinicaltrials.gov ↗

NA

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Metabolism Disorder
Cancer
Immune Checkpoint Inhibitors

Interventions

DIAGNOSTIC_TEST: calorimetry, impedance measurement at baseline and after 3 months of treatment

Sponsor

Assistance Publique - Hôpitaux de Paris